Free On-Demand CPE and CME! Follow-Up with the Experts on C. difficile Management
Ask the Experts: Existing and Novel Therapeutics in the Management of Recurrent Clostridioides difficile Infection
This 1-hour interprofessional educational activity examines recent data on Clostridioides difficile infection (CDI) and uses a case-based approach to apply recommendations to the management of recurrent CDI (rCDI). CDI is one of the most common healthcare-associated infections and the most common cause of mortality in patients with gastroenteritis in the United States. rCDI has been shown to be associated with increased morbidity, mortality, and healthcare costs, as well as having a negative impact on the patient’s quality of life. Recent updates to guidelines have resulted in practitioners having varying treatment and management options for CDI. This webinar will review the pathogenesis of CDI that can lead to rCDI episodes and explore the role of current and emerging therapeutics in the interprofessional management of rCDI.
Please note: when accessing our eLearning system, activities for this initiative can be completed in any order.
Featuring... |
 |
Anne Gonzales-LunaPharmD, BCIDP
Research Assistant Professor - Infectious Diseases |
 |
Andrew SkinnerMD
Assistant Professor of Medicine |
Target AudienceThis activity was planned to meet the educational needs of pharmacists, physicians, and other healthcare providers who care for patients with Clostridioides difficile infection. |
Learning Objectives
|
AgendaWelcome and Introductions
|
Accredited for CPE and CMEACPE #:0204-0000-23-404-H01-P CE Credit: 1.0 contact hours (0.10 CEUs) Activity Type: Application-based Activity Fee: No charge
To receive CE credit, complete the steps below within 60 days of completing the activity. 1. View entire presentation and answer all polling questions. After the 60-day deadline, ASHP will no longer be able to report credit(s). |